Providing a diverse range of perspectives from bullish to bearish, 11 analysts have published ratings on Pacific Biosciences (NASDAQ:PACB) in the last three months.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish |
---|
Total Ratings | 3 | 2 | 6 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 3 | 0 | 0 |
2M Ago | 2 | 2 | 3 | 0 | 0 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts have set 12-month price targets for Pacific Biosciences, revealing an average target of $3.64, a high estimate of $8.00, and a low estimate of $2.00. A decline of 57.92% from the prior average price target is evident in the current average.
Diving into Analyst Ratings: An In-Depth Exploration
The analysis of recent analyst actions sheds light...
在過去三個月中,有11位分析師公佈了對Pacific Biosciences(納斯達克股票代碼:PACB)的評級,提供了從看漲到看跌的不同視角。
下表總結了他們最近的評級,展示了過去30天內不斷變化的情...